<DOC>
	<DOCNO>NCT01033331</DOCNO>
	<brief_summary>The purpose study determine treatment valproic acid increase muscle strength motor ability child spinal muscular atrophy .</brief_summary>
	<brief_title>Evaluation Muscle Strength Motor Ability Children With Spinal Muscle Atrophy ( SMA ) Treated With Valproic Acid</brief_title>
	<detailed_description>Spinal muscular atrophy ( SMA ) autosomal recessive disorder affect motoneuron spinal anterior corn , result hypotonia muscle weakness . The knowledge molecular mechanism lead clinical test drug increase survival motor neuron ( SMN ) protein level . The valproic acid ( VA ) act histone deacetylase inhibitor activate SMN2 gene increase protein level . Methods : Twenty-two patient type II III SMA , age 2 18 year old , treat VA evaluate five time along period one year use Manual Muscle Test ( Medical Research Council scale-MRC ) , Hammersmith Motor Ability Score , Barthel Index . The first evaluation coincident introduction VA . Results : After 12 month therapy , patient gain muscle strength motor ability improve . Children young 6 year age high pronounced gain motor ability . Conclusion : treatment SMA patient VA one alternative alleviate progression disease .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Muscular Atrophy , Spinal</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Regularly attend Outpatient Service Neuromuscular Disorders Child Neurology Institution ; More 2 year olf molecular analysis Spinal Muscular Atrophy ; Had submit surgery recently ; Did come evaluation medical session : Did take medication correctly</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Spinal Muscular atrophy</keyword>
	<keyword>Valproic acid</keyword>
	<keyword>HMAS</keyword>
	<keyword>MRC scale</keyword>
</DOC>